About Aesculapius
Aesculapius was established in 1959 in Brescia, Italy, within the pharmaceutical sector. A variety of products is developed and distributed, encompassing medicines with original active ingredients and formulations, food supplements, cosmetics, and medical devices. Operations focus on innovation and compliance in the healthcare industry, serving markets through established supply chains in Europe.
- Headquarter Brescia, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Æsculapius Farmaceutici S.R.L.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Ceres Pharma
(Jan 11, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aesculapius
Detailed funding history for Aesculapius
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Aesculapius
Aesculapius has secured backing from 1 investor. Prominent investors backing the company include Ceres Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Nutritional supplements are manufactured and marketed by Ceres Pharma.
|
Locked | Locked | Locked |
Investor details for Aesculapius
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aesculapius
Investment portfolio details for Aesculapius
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aesculapius
Detailed financials for Aesculapius
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aesculapius Comparisons
Peer comparison for Aesculapius
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aesculapius
Detailed competitors of Aesculapius
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aesculapius
Complete news archive for Aesculapius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aesculapius
Aesculapius was founded in 1959.
Aesculapius is headquartered in Brescia, Italy. It is registered at Brescia, Lombardy, Italy.
Aesculapius was established in 1959 in Brescia, Italy, within the pharmaceutical sector. A variety of products is developed and distributed, encompassing medicines with original active ingredients and formulations, food supplements, cosmetics, and medical devices. Operations focus on innovation and compliance in the healthcare industry, serving markets through established supply chains in Europe.
Aesculapius has 1 investor. Key investors include Ceres Pharma.